Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Accumulated Expenses (2010 - 2026)

Veru (VERU) posted quarterly Accumulated Expenses of $382876.0 for Q1 2026, down 80.73% year-over-year from $2.0 million in Q1 2025, and down 91.58% quarter-over-quarter from $4.5 million in Q4 2025.

Veru (VERU) Accumulated Expenses (2010 - 2026) Analysis & Trends

Veru (VERU) has reported Accumulated Expenses for 17 consecutive years, with $382876.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accumulated Expenses fell 80.73% year-over-year to $382876.0; the TTM figure through Mar 2026 stood at $382876.0 (down 80.73% YoY), while the FY2025 annual figure was $394529.0, down 41.09% from the prior year.
  • Accumulated Expenses slipped to $382876.0 in Q1 2026 per VERU's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.1 million in Q4 2022 and bottomed at $100000.0 in Q3 2023.
  • Historically, Accumulated Expenses has averaged $2.7 million across 5 years, with a median of $2.4 million in 2022.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 98.33% — and 2024, when it surged 569.69%.
  • Veru's Accumulated Expenses stood at $7.1 million in 2022, then slumped by 69.82% to $2.2 million in 2023, then slumped by 30.21% to $1.5 million in 2024, then soared by 202.46% to $4.5 million in 2025, then slumped by 91.58% to $382876.0 in 2026.
  • Business Quant data shows VERU's Accumulated Expenses at $382876.0 in Q1 2026, $4.5 million in Q4 2025, and $394529.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Veru 60.85 Mn 35.06 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.72 Mn
Mar 31, 2026 382,876.00
Dec 31, 2025 4.55 Mn
Sep 30, 2025 394,529.00
Jun 30, 2025 2.78 Mn
Mar 31, 2025 1.99 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 669,685.00
Jun 30, 2024 2.19 Mn
Mar 31, 2024 2.68 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 100,000.00
Jun 30, 2023 3.55 Mn
Mar 31, 2023 2.99 Mn
Dec 31, 2022 7.14 Mn
Sep 30, 2022 5.99 Mn
Jun 30, 2022 4.02 Mn
Mar 31, 2022 2.39 Mn
Dec 31, 2021 2.02 Mn
Sep 30, 2021 4.99 Mn